Pipeline — registered trials by phase
A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
— · Posttraumatic Stress Disorder · Completed · est. 2012-10
Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen
— · Osteoarthritis, Knee · Completed
Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women
— · Postmenopause · Completed
Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
— · Meningitis, Cryptococcal, HIV Infections · Completed
A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
— · Urothelial Carcinoma · Completed · est. 2024-04-25
Adolescent Fibromyalgia Study
— · Fibromyalgia · Completed · est. 2014-12
Korea Comirnaty Post-marketing Surveillance
— · COVID-19, Vaccines, Adverse Effects · Active Not Recruiting · est. 2027-01-24
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
— · Plaque Psoriasis · Completed · est. 2009-06
Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI
— · Skin Diseases, Infectious · Completed
Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
— · Coronary Arteriosclerosis, Diabetes Mellitus, Type 2, Cerebrovascular Accident · Completed · est. 2004-02
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
— · Rheumatoid Arthritis · Completed · est. 2013-04
A Study to Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia People
— · COVID-19 · Completed · est. 2023-04-03
An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria
— · Plaque Psoriasis Patients · Completed · est. 2013-06
A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol
— · Dyslipidemias · Completed
Palbociclib in Real World Practice
— · Advanced Breast Cancer, Metastatic Breast Cancer · Completed · est. 2022-10-01
A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany
— · ATTR-CM (Transthyretin Amyloid Cardiomyopathy) · Active Not Recruiting · est. 2026-09-30
Pegvisomant And Sandostatin LAR Combination Study
— · Acromegaly · Completed
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
— · Pulmonary Arterial Hypertension · Completed · est. 2011-03-28
Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea
— · Venous Thromboembolism · Completed · est. 2021-09-30
Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
— · Transthyretin Familial Amyloid Polyneuropathy · Completed · est. 2023-03-10
Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain
— · Low Back Pain · Completed
Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction
— · Impotence, Depression · Completed
A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy
— · Diabetic Neuropathies · Completed
A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
— · Pneumococcal Immunization, Safety · Recruiting · est. 2027-03-01
An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
— · Rhematoid Arthritis · Completed · est. 2016-12
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
— · Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer · Active Not Recruiting · est. 2027-08-31
A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia
— · Schizophrenia · Completed · est. 2016-10
Study Evaluating the Safety, Tolerability and Pharmacokinetics of NSA-789 in Healthy Japanese Male Subjects
— · Healthy · Completed · est. 2008-09
A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee
— · Pain · Completed · est. 2012-10
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
— · Breast Cancer · Completed · est. 2015-12-15
Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)
— · Healthy Volunteers · Completed · est. 2013-01
A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults
— · Healthy Participants · Completed · est. 2024-02-20
Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects
— · Healthy · Completed
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
— · Diabetes Melliuts, Type 2 · Completed · est. 2013-08
A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia
— · Healthy · Completed · est. 2011-06
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
— · Parkinson's Disease · Completed · est. 2014-08
Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects
— · Healthy · Completed · est. 2009-11
A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.
— · Primary Ovarian Insufficiency, Vaginitis, Metrorrhagia · Completed · est. 2012-03
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
— · Neoplasm · Completed · est. 2020-01-08
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
— · Systemic Lupus Erythematosus, Rheumatoid Arthritis · Completed · est. 2022-02-15
Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics
— · Healthy Volunteers · Completed · est. 2015-06
Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis
— · Atopic Dermatitis · Completed · est. 2022-12-27
A Multiple Dose Study To Determine Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Healthy Adult Subjects
— · Healthy · Completed · est. 2009-12
Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate
— · Healthy · Completed · est. 2010-09
Study Evaluating IMA-638 in Asthma
— · Asthma · Completed
Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)
— · Healthy · Completed · est. 2014-12
An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule
— · Healthy · Completed · est. 2010-11
Absorption, Metabolism, Excretion and Absolute Bioavailability
— · Healthy · Completed · est. 2017-09-15
Bioequivalence Study Of Pediatric Appropriate Formulation
— · Hypercholesterolemia · Completed · est. 2009-03
A Study In Patients With Advanced Solid Tumor
— · Neoplasms · Completed · est. 2010-04
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
— · Dental Pain · Completed · est. 2008-06-20
A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects
— · Hepatitis C · Completed · est. 2008-07
Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis
— · Arthritis, Rheumatoid · Completed · est. 2008-08
A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers
— · Healthy Participants · Completed · est. 2024-05-27
A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients
— · Kidney Transplantation · Completed · est. 2006-07
A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized
— · SARS-CoV-2 Infection · Completed · est. 2023-09-13
CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer
— · Carcinoma, Breast · Completed · est. 2003-10
Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease
— · Alzheimer's Disease · Completed · est. 2014-02
A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension
— · Primary Open Angle Glaucoma, Ocular Hypertension · Completed · est. 2003-03
The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)
— · Pneumonia, Bacterial · Completed · est. 2011-04
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
— · Respiratory Tract Infection · Completed · est. 2023-10-27
Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects
— · Hemophilia A · Completed · est. 2009-12
Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance
— · Restless Legs Syndrome · Completed · est. 2011-06
Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico
— · Vaccines, Pneumococcal · Completed · est. 2010-05
Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain
— · Pain · Completed · est. 2010-07
Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis
— · ATTR-PN · Completed · est. 2020-07-08
A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.
— · Fibromyalgia · Completed · est. 2009-05
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
— · Chronic Myeloid Leukemia · Completed · est. 2010-08-31
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
— · Bipolar Disorder · Completed · est. 2007-07
Study Evaluating rFIX; BeneFIX in Severe Hemophilia B
— · Hemophilia B · Completed
Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
— · Major Depressive Disorder · Completed · est. 2005-05
A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients
— · NSCLC (Non-small Cell Lung Cancer) · Completed · est. 2015-06-30
A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
— · Coronary Disease, Coronary Arteriosclerosis, Hyperlipidemia · Completed
Study Evaluating Venlafaxine ER in Patients With Panic Disorder
— · Panic Disorder · Completed · est. 2003-04
A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease
— · Gaucher Disease · Completed · est. 2014-07
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).
— · Rheumatoid Arthritis · Completed · est. 2016-08-31
ArthrotecDiclofenac Sodium
CaverjectAlprostadil
Caverject ImpulseAlprostadil
CleocinClindamycin Palmitate Hydrochloride
Cleocin HydrochlorideClindamycin Hydrochloride
ColestidColestipol Hydrochloride
Depo-EstradiolEstradiol Cypionate
Depo-MedrolMethylprednisolone Acetate
Depo-ProveraMedroxyprogesterone Acetate
Depo-Subq Provera 104Medroxyprogesterone Acetate
DiflucanFluconazole
Doxorubicin HydrochlorideDoxorubicin Hydrochloride
EraxisAnidulafungin
FeldenePiroxicam
FlagylMetronidazole
FragminDalteparin Sodium
Glucotrol XlGlipizide
HalcionTriazolam
Heparin Sodium Preservative FreeHeparin Sodium
Idamycin PfsIdarubicin Hydrochloride
Idarubicin HydrochlorideIdarubicin Hydrochloride
LincocinLincomycin Hydrochloride
LitfuloRitlecitinib Tosylate
LomotilAtropine Sulfate
LorbrenaLorlatinib
MedrolMethylprednisolone
NorpaceDisopyramide Phosphate
Ogen 5Estropipate
PfizerpenPenicillin G Potassium
PrepidilDinoprostone
TalzennaTalazoparib Tosylate
TessalonBenzonatate
TikosynDofetilide
VelsipityEtrasimod Arginine
VfendVoriconazole
ZithromaxAzithromycin
ZyvoxLinezolid
Source: ClinicalTrials.gov (trials where Pfizer is lead sponsor; 78 active or completed) and Drugs@FDA (37 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- N-PX2026-08-31N-PX
- 13F-HR2026-08-1313F-HR
- 10-Q2026-08-04Quarterly report
- 8-K2026-08-04Current report (material event)
- 8-K2026-06-18Current report (material event)
- 8-K2026-06-18Current report (material event)
- 11-K2026-06-1611-K
- 11-K2026-06-1611-K
- SCHEDULE 13G/A2026-05-12SCHEDULE 13G/A
- 13F-HR2026-05-1213F-HR
- S-82026-05-05Employee stock plan
- 10-Q2026-05-05Quarterly report
- 8-K2026-05-05Current report (material event)
- SCHEDULE 13G2026-05-01SCHEDULE 13G
- 8-K2026-04-27Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- ARS2026-03-12Annual report to holders
- DEFA14A2026-03-12DEFA14A
- DEF 14A2026-03-12Proxy statement
- 10-K2026-02-26Annual report
- SCHEDULE 13D/A2026-02-13SCHEDULE 13D/A
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- 13F-HR2026-02-1213F-HR
- 8-K2026-02-03Current report (material event)
- 8-K2025-12-16Current report (material event)
- 8-K2025-11-21Current report (material event)
- 424B52025-11-20Prospectus (offering)
- FWP2025-11-19FWP
- 424B32025-11-18424B3
- 13F-HR2025-11-1313F-HR
- 8-K2025-11-13Current report (material event)
- 10-Q2025-11-04Quarterly report
- 8-K2025-11-04Current report (material event)
- 13F-HR2025-08-1113F-HR
- 10-Q2025-08-05Quarterly report
- 8-K2025-08-05Current report (material event)
- 11-K2025-06-1611-K
- 11-K2025-06-1611-K
- SD2025-05-30SD
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.